FDA approves new dosing option for AZ’s Imfinzi
admin 24th November 2020 Uncategorised 0Less-frequent, fixed-dose use approved for two cancer indications More: FDA approves new dosing option for AZ’s Imfinzi Source: News
read moreLess-frequent, fixed-dose use approved for two cancer indications More: FDA approves new dosing option for AZ’s Imfinzi Source: News
read moreMenQuadfi approved for vaccination in individuals 12 months of age or older More: Sanofi’s meningococcal vaccine wins EU approval Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals